Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colonic Iron Administration with WMT for Iron Deficiency
NCT06487299Phase 2Not yet recruiting
- Sponsor
- The Second Affiliated Hospital of Nanjing Medical University
- Start
- Jul 2024
- Primary completion
- Jan 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of ferrous lactate in iron deficiency anemia (IDA) (3 arms), sponsored by The Second Affiliated Hospital of Nanjing Medical University. Primary endpoint: Reticulocyte haemoglobin values in blood at Day 4. Planned start Jul 2024; status: not yet recruiting.
02
Drugs
ferrous lactate
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT06487299.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06487299.